TR200201762T2 - B östrojen reseptörü ligandları. - Google Patents
B östrojen reseptörü ligandları.Info
- Publication number
- TR200201762T2 TR200201762T2 TR2002/01762T TR200201762T TR200201762T2 TR 200201762 T2 TR200201762 T2 TR 200201762T2 TR 2002/01762 T TR2002/01762 T TR 2002/01762T TR 200201762 T TR200201762 T TR 200201762T TR 200201762 T2 TR200201762 T2 TR 200201762T2
- Authority
- TR
- Turkey
- Prior art keywords
- estrogen receptor
- receptor ligands
- administering
- carries
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Asagidaki genel yapiyi tasiyan bir bilesigin terapötik olarak etkili bir miktarinin uygulanmasi asamasindan olusan, öströjen reseptörü-B ile iliskili bir yöntemin tedavisi için bir yöntem.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12990199P | 1999-04-16 | 1999-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200201762T2 true TR200201762T2 (tr) | 2002-10-21 |
Family
ID=22442124
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/01762T TR200201762T2 (tr) | 1999-04-16 | 2000-04-11 | B östrojen reseptörü ligandları. |
TR2001/02992T TR200102992T2 (tr) | 1999-04-16 | 2000-04-11 | ß östrojen reseptörü ligandları. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02992T TR200102992T2 (tr) | 1999-04-16 | 2000-04-11 | ß östrojen reseptörü ligandları. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6518301B1 (tr) |
EP (1) | EP1173164A2 (tr) |
JP (1) | JP2002542187A (tr) |
KR (1) | KR20010108509A (tr) |
CN (1) | CN1358091A (tr) |
AR (1) | AR043085A1 (tr) |
AU (1) | AU4128800A (tr) |
BG (1) | BG106103A (tr) |
BR (1) | BR0009814A (tr) |
CA (1) | CA2370126A1 (tr) |
CZ (1) | CZ20013714A3 (tr) |
EE (1) | EE200100526A (tr) |
HU (1) | HUP0200740A3 (tr) |
IL (1) | IL145839A0 (tr) |
IS (1) | IS6108A (tr) |
MX (1) | MXPA01010423A (tr) |
NO (1) | NO20015015L (tr) |
PL (1) | PL351314A1 (tr) |
SK (1) | SK14762001A3 (tr) |
TR (2) | TR200201762T2 (tr) |
WO (1) | WO2000062765A2 (tr) |
ZA (1) | ZA200108409B (tr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
JP2004510815A (ja) * | 2000-10-13 | 2004-04-08 | アストラゼネカ・アクチエボラーグ | エストロゲン受容体−βリガンド |
GB2361642A (en) * | 2000-10-24 | 2001-10-31 | Karobio Ab | Estrogen receptor beta (ERbeta) agonists for use in cancer treatment |
EP1341765A1 (en) * | 2000-12-07 | 2003-09-10 | AstraZeneca AB | Therapeutic compounds |
US20070004713A1 (en) * | 2000-12-07 | 2007-01-04 | Bernard Barlaam | Therapeutic benimidazole compounds |
US6559177B2 (en) | 2001-04-19 | 2003-05-06 | Wyeth | 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents |
ATE362471T1 (de) | 2001-11-19 | 2007-06-15 | Lilly Co Eli | Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta |
UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
TW200301107A (en) | 2001-12-13 | 2003-07-01 | Wyeth Corp | Substituted 6H-dibenzo[c,h]chromenes as estrogenic agents |
TWI306450B (en) * | 2001-12-13 | 2009-02-21 | Wyeth Corp | Substituted phenyl naphthalenes as estrogenic agents |
US6835745B2 (en) | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
US7235539B2 (en) | 2002-01-23 | 2007-06-26 | Wyeth | 6-Hydroxyequilenins as estrogenic agents |
WO2003074044A1 (en) * | 2002-03-01 | 2003-09-12 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
CN101965974A (zh) | 2002-07-24 | 2011-02-09 | 儿童医院医疗中心 | 含有对映体牛尿酚的组合物和产物及其用途 |
US8668914B2 (en) * | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
AU2003255232A1 (en) * | 2002-08-07 | 2004-02-25 | University Of Mississippi | Antigiardial agents and use thereof |
CA2504682A1 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
US8580846B2 (en) * | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
US7674783B2 (en) * | 2002-11-22 | 2010-03-09 | Dimera Inc. | Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease |
CN100374444C (zh) | 2003-04-21 | 2008-03-12 | 伊莱利利公司 | 作为选择性β-***受体激动剂的取代的苯并吡喃化合物 |
JP5220406B2 (ja) * | 2004-04-28 | 2013-06-26 | ブリガム・ヤング・ユニバーシティ | 皮膚疾患を処置するためのエクオールの使用 |
SV2006002205A (es) * | 2004-08-26 | 2006-09-14 | Wyeth Corp | Prodroga de benzoxazoles substituidos como agentes estrogenicos ref. wyth0108-504 (am101763) |
AU2005282554A1 (en) | 2004-09-07 | 2006-03-16 | Wyeth | 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
CN101321524A (zh) * | 2004-12-17 | 2008-12-10 | 惠氏公司 | ***β激动剂的新用途 |
US8093302B2 (en) * | 2005-02-15 | 2012-01-10 | Eli Lilly And Company | Substituted tetralins as selective estrogen receptor-β agonists |
CA2602549A1 (en) * | 2005-03-24 | 2006-10-19 | Novogen Research Pty Ltd | Anti-inflammatory modalities |
US20070135407A1 (en) * | 2005-11-28 | 2007-06-14 | Steiner Mitchell S | Serm reduction of lipid profiles |
US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US8546451B2 (en) | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US8637706B2 (en) | 2005-11-28 | 2014-01-28 | Gtx, Inc. | Nuclear receptor binding agents |
US8158828B2 (en) * | 2005-11-28 | 2012-04-17 | Gtx, Inc. | Nuclear receptor binding agents |
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
WO2009026657A1 (en) * | 2007-08-29 | 2009-03-05 | The University Of Sydney | Flavonoid ppar agonists |
WO2010049044A1 (de) * | 2008-10-29 | 2010-05-06 | Merck Patent Gmbh | Flüssigkristallanzeige |
TWI492943B (zh) | 2008-12-05 | 2015-07-21 | 大塚製藥股份有限公司 | 喹啉酮化合物及藥學組成物(二) |
ES2343347B2 (es) * | 2009-01-27 | 2011-12-07 | Universidade De Santiago De Compostela | Uso de derivados de 3-fenilcumarinas 6-sustituidas y preparacion de nuevos derivados. |
US9624161B2 (en) | 2009-02-23 | 2017-04-18 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US9427418B2 (en) | 2009-02-23 | 2016-08-30 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
CN101863867B (zh) * | 2009-04-14 | 2012-07-18 | 清华大学深圳研究生院 | 黄酮类化合物的衍生物及其制备方法与应用 |
EP2705047B1 (en) | 2011-04-25 | 2015-08-05 | Council of Scientific & Industrial Research | Bioactive fractions and compounds from dalbergia sissoo for the prevention or treatment of osteo-health related disorders |
CN103450134B (zh) * | 2012-05-31 | 2017-12-22 | 中国医学科学院药物研究所 | 香豆素衍生物的制备及其在防治脑部重大疾病中的应用 |
US9718799B2 (en) * | 2015-05-11 | 2017-08-01 | University Of Kentucky Research Foundation | 3-aryl-4H-chromene-4-ones as antineoplastic agents for the treatment of cancer |
EP3796905A4 (en) * | 2018-05-23 | 2022-02-16 | The Board of Trustees of the University of Illinois | ESTROGEN RECEPTOR BETA LIGANDS FOR THE PREVENTION AND TREATMENT OF MULTIPLE SCLEROSIS (MS) AND OTHER DEMYELINIZING, INFLAMMATORY AND NEURODEGENERATIVE DISEASES |
EP3597187A1 (en) * | 2018-07-16 | 2020-01-22 | Centre National De La Recherche Scientifique | Brag2 inhibitors and applications thereof |
CN112574177B (zh) * | 2020-12-21 | 2023-01-31 | 陕西师范大学 | 一类嘧啶衍生物及其制备抗肿瘤药物的应用 |
CN115322198A (zh) * | 2022-06-13 | 2022-11-11 | 上海工程技术大学 | 基于喹诺里西啶类衍生物的药物化合物及其制备方法和应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4954371A (tr) * | 1972-09-28 | 1974-05-27 | ||
GB1495189A (en) * | 1975-09-12 | 1977-12-14 | Pfizer Ltd | 4-oxo-4h-benzopyran derivatives and process for their preparation |
JPS6048924A (ja) * | 1983-08-24 | 1985-03-16 | Takeda Chem Ind Ltd | 骨粗鬆症治療剤 |
ZA873745B (en) * | 1986-06-04 | 1988-10-26 | Daiichi Seiyaku Co | Benzopyran derivatives |
JP3085464B2 (ja) * | 1990-05-24 | 2000-09-11 | コニカ株式会社 | 感熱拡散転写材料 |
US5204369A (en) * | 1991-07-01 | 1993-04-20 | The Endowment For Research In Human Biology | Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
JPH05112552A (ja) * | 1991-10-17 | 1993-05-07 | Tanabe Seiyaku Co Ltd | ベンゾピラン誘導体及びその製法 |
JP3166093B2 (ja) * | 1993-08-13 | 2001-05-14 | 森永乳業株式会社 | クマリン誘導体及びそれらの用途 |
JPH06321752A (ja) * | 1993-05-07 | 1994-11-22 | Kao Corp | 美白剤 |
JP3522754B2 (ja) * | 1993-12-16 | 2004-04-26 | マリンクロッド・インコーポレイテッド | 多価フェノール化合物類 |
US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
JP3786447B2 (ja) * | 1995-03-31 | 2006-06-14 | エーザイ株式会社 | C型肝炎の予防・治療剤 |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
US5916916A (en) | 1996-10-10 | 1999-06-29 | Eli Lilly And Company | 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
US5733926A (en) * | 1996-12-13 | 1998-03-31 | Gorbach; Sherwood L. | Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
GB9707013D0 (en) * | 1997-04-07 | 1997-05-28 | Univ Strathclyde | Halo and/or nitro-substituted flavonoids |
EP0979074A4 (en) | 1997-05-01 | 2003-07-09 | Novogen Inc | TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS |
-
2000
- 2000-04-11 CN CN00809003A patent/CN1358091A/zh active Pending
- 2000-04-11 BR BR0009814-0A patent/BR0009814A/pt not_active IP Right Cessation
- 2000-04-11 TR TR2002/01762T patent/TR200201762T2/tr unknown
- 2000-04-11 SK SK1476-2001A patent/SK14762001A3/sk unknown
- 2000-04-11 EE EEP200100526A patent/EE200100526A/xx unknown
- 2000-04-11 TR TR2001/02992T patent/TR200102992T2/tr unknown
- 2000-04-11 US US09/959,032 patent/US6518301B1/en not_active Expired - Fee Related
- 2000-04-11 HU HU0200740A patent/HUP0200740A3/hu unknown
- 2000-04-11 IL IL14583900A patent/IL145839A0/xx unknown
- 2000-04-11 KR KR1020017013143A patent/KR20010108509A/ko not_active Application Discontinuation
- 2000-04-11 AU AU41288/00A patent/AU4128800A/en not_active Abandoned
- 2000-04-11 WO PCT/GB2000/001380 patent/WO2000062765A2/en not_active Application Discontinuation
- 2000-04-11 CA CA002370126A patent/CA2370126A1/en not_active Abandoned
- 2000-04-11 JP JP2000611902A patent/JP2002542187A/ja active Pending
- 2000-04-11 PL PL00351314A patent/PL351314A1/xx not_active Application Discontinuation
- 2000-04-11 CZ CZ20013714A patent/CZ20013714A3/cs unknown
- 2000-04-11 EP EP00920872A patent/EP1173164A2/en not_active Withdrawn
- 2000-04-11 MX MXPA01010423A patent/MXPA01010423A/es unknown
- 2000-04-14 AR ARP000101771A patent/AR043085A1/es unknown
-
2001
- 2001-10-12 ZA ZA200108409A patent/ZA200108409B/xx unknown
- 2001-10-15 NO NO20015015A patent/NO20015015L/no not_active Application Discontinuation
- 2001-10-15 IS IS6108A patent/IS6108A/is unknown
- 2001-11-13 BG BG106103A patent/BG106103A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20015015D0 (no) | 2001-10-15 |
HUP0200740A2 (hu) | 2002-07-29 |
EE200100526A (et) | 2002-12-16 |
SK14762001A3 (sk) | 2002-10-08 |
US6518301B1 (en) | 2003-02-11 |
CZ20013714A3 (cs) | 2002-08-14 |
AR043085A1 (es) | 2005-07-20 |
KR20010108509A (ko) | 2001-12-07 |
IS6108A (is) | 2001-10-15 |
MXPA01010423A (es) | 2002-03-27 |
TR200102992T2 (tr) | 2004-12-21 |
AU4128800A (en) | 2000-11-02 |
EP1173164A2 (en) | 2002-01-23 |
ZA200108409B (en) | 2003-03-26 |
WO2000062765A2 (en) | 2000-10-26 |
BG106103A (en) | 2002-05-31 |
NO20015015L (no) | 2001-12-17 |
JP2002542187A (ja) | 2002-12-10 |
CN1358091A (zh) | 2002-07-10 |
IL145839A0 (en) | 2002-07-25 |
CA2370126A1 (en) | 2000-10-26 |
BR0009814A (pt) | 2002-01-08 |
WO2000062765A3 (en) | 2001-09-07 |
HUP0200740A3 (en) | 2004-08-30 |
PL351314A1 (en) | 2003-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200201762T2 (tr) | B östrojen reseptörü ligandları. | |
IT248598Y1 (it) | Scudo per la protezione dorsale. | |
DK1037607T3 (da) | Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse | |
PT1459748E (pt) | (s,s)-reboxetina para tratar a neuropatia periferica | |
NO20000657L (no) | Ikke-steroidale ligander for østrogen reseptor | |
AP9801312A0 (en) | 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor anatagonist. | |
GB0031527D0 (en) | New use | |
ES2160410T3 (es) | Preparados de complejos de protrombina inmunotolerantes. | |
ITBO980564A0 (it) | Macchina tessile circolare per maglieria . | |
TR200101337T2 (tr) | Değiştirilmiş salımlı ensülin sensitizörü için farmasötik terkip ve kullanımı. | |
AP2001002220A0 (en) | Calcilytic compounds. | |
FR2802955B1 (fr) | Gabarit de positionnement pour elements de carrelage | |
TR200102944T2 (tr) | İntegrin reseptör ligandları | |
AU1160700A (en) | Ppar gamma ligands | |
ES538649A0 (es) | Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos. | |
TR200103841T2 (tr) | Tümör büyümesini önlemek için yöntem. | |
NL1001173C1 (nl) | Inbouwset voor armaturen. | |
IT1284537B1 (it) | Macchina circolare per maglieria | |
TR200102576T2 (tr) | Kanser tedavisinde radyoaktif sisplatin | |
TR200103288T2 (tr) | Tio-oksindol türevleri | |
DK0978485T3 (da) | Føderørsløftesystem til forherd | |
CA2305432A1 (en) | Method for preventing the misuse of a transdermal therapeutic system | |
IT1303585B1 (it) | Supporto metallico per un catalizzatore. | |
TR200103126T2 (tr) | Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri | |
IT1318792B1 (it) | Gruppo piastra fissa per macchina i.s. |